- Home
- HOUR vs QNCX Comparison
HOUR vs QNCX Comparison
Compare HOUR & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOUR
- QNCX
- Stock Information
- Founded
- HOUR 2015
- QNCX 2012
- Country
- HOUR United States
- QNCX United States
- Employees
- HOUR N/A
- QNCX N/A
- Industry
- HOUR Catalog/Specialty Distribution
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HOUR Consumer Discretionary
- QNCX Health Care
- Exchange
- HOUR Nasdaq
- QNCX Nasdaq
- Market Cap
- HOUR 47.1M
- QNCX 47.7M
- IPO Year
- HOUR 2022
- QNCX 2019
- Fundamental
- Price
- HOUR $1.40
- QNCX $1.50
- Analyst Decision
- HOUR
- QNCX Strong Buy
- Analyst Count
- HOUR 0
- QNCX 5
- Target Price
- HOUR N/A
- QNCX $8.00
- AVG Volume (30 Days)
- HOUR 22.8K
- QNCX 303.0K
- Earning Date
- HOUR 08-08-2025
- QNCX 08-12-2025
- Dividend Yield
- HOUR N/A
- QNCX N/A
- EPS Growth
- HOUR N/A
- QNCX N/A
- EPS
- HOUR 0.01
- QNCX N/A
- Revenue
- HOUR $139,408,829.00
- QNCX N/A
- Revenue This Year
- HOUR N/A
- QNCX N/A
- Revenue Next Year
- HOUR N/A
- QNCX N/A
- P/E Ratio
- HOUR $204.11
- QNCX N/A
- Revenue Growth
- HOUR 2.71
- QNCX N/A
- 52 Week Low
- HOUR $0.83
- QNCX $0.51
- 52 Week High
- HOUR $6.90
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- HOUR 55.80
- QNCX 65.33
- Support Level
- HOUR $1.30
- QNCX $1.29
- Resistance Level
- HOUR $1.53
- QNCX $1.62
- Average True Range (ATR)
- HOUR 0.10
- QNCX 0.11
- MACD
- HOUR 0.02
- QNCX 0.03
- Stochastic Oscillator
- HOUR 48.78
- QNCX 74.47
About HOUR Hour Loop Inc.
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.